National Planning Corporation’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,635
Closed -$1.7M 702
2017
Q3
$1.7M Buy
11,635
+193
+2% +$26.3K 0.14% 159
2017
Q2
$1.49M Buy
11,442
+1,005
+10% +$123K 0.11% 205
2017
Q1
$1.3M Buy
10,437
+1,738
+20% +$208K 0.1% 199
2016
Q4
$1M Sell
8,699
-2,652
-23% -$295K 0.08% 236
2016
Q3
$1.22M Sell
11,351
-560
-5% -$60.6K 0.1% 209
2016
Q2
$1.36M Buy
11,911
+1,899
+19% +$196K 0.11% 198
2016
Q1
$1M Sell
10,012
-2,720
-21% -$280K 0.09% 228
2015
Q4
$1.25M Buy
12,732
+6,334
+99% +$733K 0.1% 219
2015
Q3
$814K Buy
6,398
+784
+14% +$97.3K 0.07% 253
2015
Q2
$734K Buy
5,614
+786
+16% +$89.9K 0.07% 274
2015
Q1
$519K Sell
4,828
-7,528
-61% -$900K 0.05% 348
2014
Q4
$1.42M Sell
12,356
-6,252
-34% -$659K 0.1% 185
2014
Q3
$1.77M Buy
18,608
+1,150
+7% +$104K 0.13% 152
2014
Q2
$1.5M Sell
17,458
-3,002
-15% -$228K 0.12% 180
2014
Q1
$1.51M Sell
20,460
-3,946
-16% -$312K 0.13% 163
2013
Q4
$2.06M Buy
24,406
+1,416
+6% +$112K 0.18% 121
2013
Q3
$1.81M Buy
22,990
+6,610
+40% +$463K 0.18% 132
2013
Q2
$961K Buy
+16,380
New +$986K 0.12% 184

Other funds holding CELG

National Planning Corporation's CELG Position: Q4 2017 in Review

National Planning Corporation sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 11,635 shares — an estimated $1.7M sold.

National Planning Corporation first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $2.06M in Q4 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • National Planning Corporation reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 11,635 Celgene Corp shares in Q4 2017, an estimated $1.7M.
  • National Planning Corporation first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Celgene Corp position peaked at $2.06M in Q4 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.